Skip to main content
Quest Diagnostics

Genetic Findings From a Multigene Panel for Autoinflammatory Disease

Clinical Immunology Society,

CIS 2023 Annual Meeting: Immune Deficiency and Dysregulation Norht American Conference

St Louis, M, May 18-21, 2023

Poster presentation: Genetic findings from a multigene panel for autoinflammatory disease

Authors:  Howell V, Gall K, Scocchia A, Koskinen L, Saarinen I, Gentile M, Salmenperä P, Paananen J, Myllykangas S, Koskenvuo J

Specialties: Genetics, Infectious Disease

Disclaimer: One or more of the authors of this publication were employed at the time by BluePrint Genetics, a subsidiary of Quest Diagnostics.

Related content

On-Demand Webinar
Autoimmune Testing Essentials in Primary Care to Guide Rheumatology Referrals

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.